Annual EBIT:
$20.84M+$120.79M(+120.85%)Summary
- As of today, FOLD annual earnings before interest & taxes is $20.84 million, with the most recent change of +$120.79 million (+120.85%) on December 31, 2024.
- During the last 3 years, FOLD annual EBIT has risen by +$229.93 million (+109.97%).
- FOLD annual EBIT is now at all-time high.
Performance
FOLD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$34.27M+$42.04M(+540.93%)Summary
- As of today, FOLD quarterly earnings before interest & taxes is $34.27 million, with the most recent change of +$42.04 million (+540.93%) on September 30, 2025.
- Over the past year, FOLD quarterly EBIT has increased by +$9.47 million (+38.17%).
- FOLD quarterly EBIT is now -0.57% below its all-time high of $34.46 million, reached on December 31, 2009.
Performance
FOLD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$34.52M+$9.47M(+37.79%)Summary
- As of today, FOLD TTM earnings before interest & taxes is $34.52 million, with the most recent change of +$9.47 million (+37.79%) on September 30, 2025.
- Over the past year, FOLD TTM EBIT has increased by +$20.11 million (+139.68%).
- FOLD TTM EBIT is now -27.77% below its all-time high of $47.79 million, reached on March 31, 2025.
Performance
FOLD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
FOLD EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +120.8% | +38.2% | +139.7% |
| 3Y3 Years | +110.0% | +203.0% | +114.7% |
| 5Y5 Years | +106.2% | +166.3% | +112.9% |
FOLD EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +110.0% | at high | +184.1% | -27.8% | +114.7% |
| 5Y | 5-Year | at high | +106.2% | at high | +148.7% | -27.8% | +112.9% |
| All-Time | All-Time | at high | +104.8% | -0.6% | +122.1% | -27.8% | +109.1% |
FOLD EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $34.27M(+540.9%) | $34.52M(+37.8%) |
| Jun 2025 | - | -$7.77M(+2.3%) | $25.05M(-47.6%) |
| Mar 2025 | - | -$7.95M(-149.8%) | $47.79M(+40.3%) |
| Dec 2024 | $20.84M(+120.9%) | $15.97M(-35.6%) | $34.06M(+136.5%) |
| Sep 2024 | - | $24.80M(+65.7%) | $14.40M(+156.6%) |
| Jun 2024 | - | $14.97M(+169.0%) | -$25.43M(+56.0%) |
| Mar 2024 | - | -$21.68M(-487.1%) | -$57.78M(+21.4%) |
| Dec 2023 | -$99.95M(+51.2%) | -$3.69M(+75.4%) | -$73.49M(+33.5%) |
| Sep 2023 | - | -$15.03M(+13.6%) | -$110.55M(+14.2%) |
| Jun 2023 | - | -$17.39M(+53.5%) | -$128.79M(+25.1%) |
| Mar 2023 | - | -$37.38M(+8.2%) | -$171.90M(+15.9%) |
| Dec 2022 | -$204.92M(+2.0%) | -$40.74M(-22.5%) | -$204.43M(+12.7%) |
| Sep 2022 | - | -$33.27M(+45.0%) | -$234.09M(+2.4%) |
| Jun 2022 | - | -$60.50M(+13.5%) | -$239.93M(-10.4%) |
| Mar 2022 | - | -$69.91M(+0.7%) | -$217.25M(-8.7%) |
| Dec 2021 | -$209.08M(+17.0%) | -$70.41M(-80.0%) | -$199.92M(-3.1%) |
| Sep 2021 | - | -$39.11M(-3.4%) | -$193.88M(+6.1%) |
| Jun 2021 | - | -$37.81M(+28.1%) | -$206.50M(+5.8%) |
| Mar 2021 | - | -$52.58M(+18.3%) | -$219.31M(+10.1%) |
| Dec 2020 | -$251.83M(+25.3%) | -$64.37M(-24.4%) | -$243.85M(+9.0%) |
| Sep 2020 | - | -$51.73M(-2.2%) | -$267.86M(+1.8%) |
| Jun 2020 | - | -$50.63M(+34.4%) | -$272.65M(+8.5%) |
| Mar 2020 | - | -$77.13M(+12.7%) | -$297.97M(+0.9%) |
| Dec 2019 | -$337.04M(-3.2%) | -$88.38M(-56.4%) | -$300.74M(-6.9%) |
| Sep 2019 | - | -$56.52M(+25.6%) | -$281.25M(+25.9%) |
| Jun 2019 | - | -$75.95M(+4.9%) | -$379.61M(-8.4%) |
| Mar 2019 | - | -$79.90M(-16.0%) | -$350.29M(-7.6%) |
| Dec 2018 | -$326.69M(+24.4%) | -$68.88M(+55.5%) | -$325.48M(-1.7%) |
| Sep 2018 | - | -$154.88M(-232.1%) | -$319.97M(-46.0%) |
| Jun 2018 | - | -$46.63M(+15.3%) | -$219.15M(-0.3%) |
| Mar 2018 | - | -$55.08M(+13.1%) | -$218.53M(-3.6%) |
| Dec 2017 | -$431.88M(-117.7%) | -$63.38M(-17.2%) | -$210.88M(-7.9%) |
| Sep 2017 | - | -$54.05M(-17.5%) | -$195.38M(-2.6%) |
| Jun 2017 | - | -$46.01M(+3.0%) | -$190.36M(-4.2%) |
| Mar 2017 | - | -$47.44M(+0.9%) | -$182.70M(-4.4%) |
| Dec 2016 | -$198.38M(-52.0%) | -$47.88M(+2.4%) | -$175.06M(-4.7%) |
| Sep 2016 | - | -$49.04M(-27.9%) | -$167.28M(-9.9%) |
| Jun 2016 | - | -$38.35M(+3.6%) | -$152.18M(-8.9%) |
| Mar 2016 | - | -$39.80M(+0.7%) | -$139.70M(-13.6%) |
| Dec 2015 | -$130.54M | -$40.09M(-18.1%) | -$122.94M(-17.8%) |
| Sep 2015 | - | -$33.94M(-31.2%) | -$104.34M(-18.8%) |
| Jun 2015 | - | -$25.86M(-12.2%) | -$87.80M(-14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$23.05M(-7.3%) | -$76.59M(-11.5%) |
| Dec 2014 | -$68.56M(-8.6%) | -$21.49M(-23.5%) | -$68.66M(-13.5%) |
| Sep 2014 | - | -$17.40M(-18.8%) | -$60.48M(-3.9%) |
| Jun 2014 | - | -$14.65M(+3.1%) | -$58.21M(+2.3%) |
| Mar 2014 | - | -$15.12M(-13.7%) | -$59.57M(+3.4%) |
| Dec 2013 | -$63.10M(-21.5%) | -$13.30M(+12.1%) | -$61.69M(+3.5%) |
| Sep 2013 | - | -$15.13M(+5.4%) | -$63.91M(+2.7%) |
| Jun 2013 | - | -$16.00M(+7.2%) | -$65.69M(-11.3%) |
| Mar 2013 | - | -$17.25M(-11.1%) | -$59.04M(-12.4%) |
| Dec 2012 | -$51.94M(-8.5%) | -$15.52M(+8.2%) | -$52.53M(-5.0%) |
| Sep 2012 | - | -$16.92M(-81.0%) | -$50.04M(-8.3%) |
| Jun 2012 | - | -$9.35M(+13.0%) | -$46.20M(+10.4%) |
| Mar 2012 | - | -$10.74M(+17.5%) | -$51.58M(-1.5%) |
| Dec 2011 | -$47.89M(+14.2%) | -$13.03M(+0.4%) | -$50.83M(+6.5%) |
| Sep 2011 | - | -$13.08M(+11.2%) | -$54.34M(+0.3%) |
| Jun 2011 | - | -$14.72M(-47.3%) | -$54.52M(-3.9%) |
| Mar 2011 | - | -$10.00M(+39.5%) | -$52.49M(+6.0%) |
| Dec 2010 | -$55.81M(-787.5%) | -$16.54M(-24.7%) | -$55.84M(-1054.4%) |
| Sep 2010 | - | -$13.27M(-4.6%) | -$4.84M(+4.1%) |
| Jun 2010 | - | -$12.69M(+5.0%) | -$5.05M(+18.8%) |
| Mar 2010 | - | -$13.35M(-138.7%) | -$6.21M(-6.5%) |
| Dec 2009 | -$6.29M(+83.9%) | $34.46M(+355.8%) | -$5.83M(+89.4%) |
| Sep 2009 | - | -$13.47M(+2.7%) | -$55.17M(-8.2%) |
| Jun 2009 | - | -$13.85M(-6.8%) | -$51.00M(-7.1%) |
| Mar 2009 | - | -$12.97M(+12.8%) | -$47.64M(-8.4%) |
| Dec 2008 | -$39.14M(+14.6%) | -$14.88M(-60.0%) | -$43.96M(-3.3%) |
| Sep 2008 | - | -$9.30M(+11.4%) | -$42.56M(+5.6%) |
| Jun 2008 | - | -$10.49M(-13.0%) | -$45.07M(-0.5%) |
| Mar 2008 | - | -$9.29M(+31.1%) | -$44.86M(+2.1%) |
| Dec 2007 | -$45.80M(+2.2%) | -$13.48M(-14.2%) | -$45.81M(-41.7%) |
| Sep 2007 | - | -$11.81M(-14.8%) | -$32.32M(-57.5%) |
| Jun 2007 | - | -$10.28M(-0.5%) | -$20.52M(-100.5%) |
| Mar 2007 | - | -$10.23M(>-9900.0%) | -$10.23M(>-9900.0%) |
| Dec 2006 | -$46.86M(-124.9%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2005 | -$20.83M(-136.5%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2005 | - | $0.00 | $0.00 |
| Dec 2004 | -$8.81M(-33.4%) | - | - |
| Dec 2003 | -$6.60M | - | - |
FAQ
- What is Amicus Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual EBIT year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Amicus Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. TTM EBIT year-on-year change?
What is Amicus Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of FOLD is $20.84M
What is the all-time high annual EBIT for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual earnings before interest & taxes is $20.84M
What is Amicus Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, FOLD annual earnings before interest & taxes has changed by +$120.79M (+120.85%)
What is Amicus Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of FOLD is $34.27M
What is the all-time high quarterly EBIT for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $34.46M
What is Amicus Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, FOLD quarterly earnings before interest & taxes has changed by +$9.47M (+38.17%)
What is Amicus Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of FOLD is $34.52M
What is the all-time high TTM EBIT for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $47.79M
What is Amicus Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, FOLD TTM earnings before interest & taxes has changed by +$20.11M (+139.68%)